Description

Chongqing Jiheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company engaged in the research, development, production and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), including products such as acetaminophen (paracetamol), with plans to integrate finished formulations. Formerly known as Chongqing Sansheng Industrial Co., Ltd., the company divested its building materials and chemicals business through a judicial restructuring completed in 2025, after which Hebei Jiheng Group became its controlling shareholder. It is headquartered in Chongqing, China.